Researchers from the U.S. Army Medical Research Institute of Infectious Diseases and Moderna published a research paper titled “Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhumanRead More…
The team of Professor Michael J. Mitchell of the University of Pennsylvania and Professor Drew Weissman, winner of the 2023 Nobel Prize in Physiology and Medicine, published a review paper titled “EnhancingRead More…
In a first-of-its-kind human clinical trial involving four adult patients, an mRNA cancer vaccine developed by the University of Florida rapidly reprograms the immune system to attack glioblastoma, the most aggressive andRead More…
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and the leading cause of cancer-related deaths worldwide. Despite advances in the treatment of advanced hepatocellular carcinoma in recent years,Read More…
Gamma delta (γδ) T cells are a type of innate-like T cell that possess dual anti-tumor activities, capable of directly eliminating tumor cells and acting as immunostimulatory cells to enhance the body’sRead More…
The development of effective vaccines for infectious diseases is one of the most successful global health interventions ever. Although subunit vaccines largely depend on the selection of antigens and adjuvants, the exposureRead More…
The trend in the field of cancer immunotherapy is the use of cancer vaccines. By using identified tumor antigens to stimulate the immune system, cancer vaccines can generate a specific immune responseRead More…
Recently, a research paper titled “Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine” was published in Cell Reports Medicine, a sub-journal of Cell.Read More…
Osteosarcoma (OS) is a highly malignant mesenchymal tumor composed of cells that produce bone-like and immature bone tissue. The peak incidence occurs in the second decade of life after birth. Although relativelyRead More…
The American Heart Association’s Basic Cardiovascular Sciences Annual Conference in 2023, recently held in Boston, USA, featured a study indicating that a novel vaccine targeting inflammatory brain cells associated with Alzheimer’s diseaseRead More…